Gelesis Holdings (Gelesis Holdings) ROCE % : -59.90% (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Gelesis Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Gelesis Holdings's annualized ROCE % for the quarter that ended in Jun. 2023 was -59.90%.

Gelesis Holdings ROCE % Historical Data

The historical data trend for Gelesis Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gelesis Holdings ROCE % Chart

Gelesis Holdings Annual Data

Trend

Dec21

Dec22

ROCE %

-119.23

-83.70

Gelesis Holdings Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
ROCE %	Get a 7-Day Free Trial					-43.73	-61.71	-136.28	-33.23	-59.90

Gelesis Holdings ROCE % Calculation

Gelesis Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	-54.309	/	( ( (146.301 - 69.166)	+	(103.324 - 50.683) )	/ 2 )
	=	-54.309	/	( (77.135	+	52.641)	/ 2 )
	=	-54.309	/	64.888
	=	-83.70 %

Gelesis Holdings's ROCE % of for the quarter that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2023 )		(Q: Mar. 2023 )		(Q: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2023 )		(Q: Mar. 2023 )		(Q: Jun. 2023 )
	=	-28.464	/	( ( (98.78 - 49.379)	+	(95.875 - 50.241) )	/ 2 )
	=	-28.464	/	( ( 49.401	+	45.634 )	/ 2 )
	=	-28.464	/	47.5175
	=	-59.90 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2023) EBIT data.

Gelesis Holdings (OTCPK:GLSWQ) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Gelesis Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of Gelesis Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Gelesis Holdings (Gelesis Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gelesis Holdings Inc (OTCPK:GLSWQ) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

501 Boylston Street, Suite 6102, Boston, MA, USA, 02116

Website

https://www.gelesis.com

Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation.